TScan Therapeutics gets Nasdaq notice over $1 minimum bid
Nasdaq notified the company that its common stock failed the $1.00 minimum bid price requirement under Listing Rule 5450(a)(1) for 30 consecutive trading days. Trading continues on Nasdaq Global Market; 180 days to Feb.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.